(19)
(11) EP 4 823 628 A1

(12)

(43) Date of publication:
21.10.2026 Bulletin 2026/43

(21) Application number: 25816315.3

(22) Date of filing: 28.05.2025
(51) International Patent Classification (IPC): 
A61K 47/68(2017.01)
A61K 39/395(2006.01)
A61P 35/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 35/00; C07K 2317/76; C07K 2317/21; C07K 16/2827; C07K 2317/92; C07K 16/32; C07K 16/303; C07K 2317/77; A61K 47/68037; A61K 47/68031; A61K 47/55; A61K 47/6855; A61K 47/6851
(86) International application number:
PCT/US2025/031110
(87) International publication number:
WO 2025/250579 (04.12.2025 Gazette 2025/49)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH LA MA MD TN

(30) Priority: 30.05.2024 US 202463653254 P

(71) Applicants:
  • Acepodia Biotechnologies Ltd.
    Taipei City, 115011 (TW)
  • Acepodia Biotech Inc.
    Alameda, CA 94502 (US)

    IE 

(72) Inventors:
  • HSIAO, Shih-Chia
    Taipei City, 115011 (TW)
  • LI, Hao-Kang
    Taipei City, 115011 (TW)
  • LAI, Cheng-Wei
    Taipei City, 115011 (TW)

(74) Representative: karo IP 
Patentanwälte PartG mbB Steinstraße 16-18
40212 Düsseldorf
40212 Düsseldorf (DE)

   


(54) A NOVEL ANTIBODY CONJUGATE, AND USES THEREOF